Marc Gitzinger

1.2k total citations
16 papers, 579 citations indexed

About

Marc Gitzinger is a scholar working on Molecular Biology, Molecular Medicine and Infectious Diseases. According to data from OpenAlex, Marc Gitzinger has authored 16 papers receiving a total of 579 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Molecular Medicine and 6 papers in Infectious Diseases. Recurrent topics in Marc Gitzinger's work include Antibiotic Resistance in Bacteria (8 papers), Tuberculosis Research and Epidemiology (6 papers) and Pneumocystis jirovecii pneumonia detection and treatment (5 papers). Marc Gitzinger is often cited by papers focused on Antibiotic Resistance in Bacteria (8 papers), Tuberculosis Research and Epidemiology (6 papers) and Pneumocystis jirovecii pneumonia detection and treatment (5 papers). Marc Gitzinger collaborates with scholars based in Switzerland, France and United States. Marc Gitzinger's co-authors include Martin Fussenegger, Christian Kemmer, Wilfried Weber, Marie Daoud El‐Baba, Vincent Trebosc, Sergio Lociuro, Thomas Grau, Peter Sander, David A. Fluri and Bettina Keller and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Marc Gitzinger

16 papers receiving 572 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marc Gitzinger Switzerland	11	354	180	73	62	60	16	579
Prateek Sharma India	12	286 0.8×	142 0.8×	89 1.2×	102 1.6×	59 1.0×	24	569
Elise Kaplan United Kingdom	10	214 0.6×	172 1.0×	45 0.6×	125 2.0×	52 0.9×	15	505
Elena Santillana Spain	8	191 0.5×	256 1.4×	158 2.2×	39 0.6×	101 1.7×	12	462
Erica J. Zheng United States	7	287 0.8×	137 0.8×	36 0.5×	103 1.7×	46 0.8×	8	505
Heng-Keat Tam Germany	12	189 0.5×	225 1.3×	44 0.6×	42 0.7×	98 1.6×	18	415
Mohd Hafidz Mahamad Maifiah Malaysia	9	211 0.6×	186 1.0×	72 1.0×	42 0.7×	73 1.2×	21	391
Kiran Tiwari United States	10	152 0.4×	124 0.7×	45 0.6×	34 0.5×	49 0.8×	25	332
Ewa Klimont United Kingdom	4	252 0.7×	280 1.6×	72 1.0×	148 2.4×	78 1.3×	4	543
Alex A. Neyfakh United States	8	323 0.9×	202 1.1×	28 0.4×	144 2.3×	95 1.6×	9	554
Daniel Andrew Aiello United States	10	253 0.7×	106 0.6×	54 0.7×	90 1.5×	34 0.6×	13	499

Countries citing papers authored by Marc Gitzinger

Since Specialization

Citations

This map shows the geographic impact of Marc Gitzinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Gitzinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Gitzinger more than expected).

Fields of papers citing papers by Marc Gitzinger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Gitzinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Gitzinger. The network helps show where Marc Gitzinger may publish in the future.

Co-authorship network of co-authors of Marc Gitzinger

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Gitzinger. A scholar is included among the top collaborators of Marc Gitzinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Gitzinger. Marc Gitzinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Pieren, Michel, Marc Gitzinger, Maria Santos Martínez, et al.. (2024). First-in-human study of alpibectir (BVL-GSK098), a novel potent anti-TB drug. Journal of Antimicrobial Chemotherapy. 79(6). 1353–1361. 2 indexed citations

Bourotte, Marilyne, Marc Gitzinger, Christian Kemmer, et al.. (2023). Structure-activity relationships of actively FhuE transported rifabutin derivatives with potent activity against Acinetobacter baumannii. European Journal of Medicinal Chemistry. 252. 115257–115257. 4 indexed citations

Trebosc, Vincent, Mohit Narwal, Marilyne Bourotte, et al.. (2022). Targeting virulence regulation to disarm Acinetobacter baumannii pathogenesis. Virulence. 13(1). 1868–1883. 7 indexed citations

Trebosc, Vincent, Marc Gitzinger, Benoît Déprez, et al.. (2022). Design and synthesis of water-soluble prodrugs of rifabutin for intraveneous administration. European Journal of Medicinal Chemistry. 238. 114515–114515. 6 indexed citations

Trebosc, Vincent, Marc Gitzinger, Benoît Déprez, et al.. (2022). Design and Synthesis of Water-Soluble Prodrugs of Rifabutin for Intraveneous Administration. SSRN Electronic Journal. 1 indexed citations

Sivignon, Adeline, Michel Pieren, Marc Gitzinger, et al.. (2021). The Role of OmpR in Bile Tolerance and Pathogenesis of Adherent-Invasive Escherichia coli. Frontiers in Microbiology. 12. 684473–684473. 12 indexed citations

Trebosc, Vincent, Christian Kemmer, Sergio Lociuro, Marc Gitzinger, & Glenn E. Dale. (2021). Rifabutin for infusion (BV100) for the treatment of severe carbapenem-resistant Acinetobacter baumannii infections. Drug Discovery Today. 26(9). 2099–2104. 15 indexed citations

Trebosc, Vincent, Marilyne Bourotte, Marc Gitzinger, et al.. (2020). In vitroactivity of rifabutin against 293 contemporary carbapenem-resistantAcinetobacter baumanniiclinical isolates and characterization of rifabutin mode of action and resistance mechanisms. Journal of Antimicrobial Chemotherapy. 75(12). 3552–3562. 28 indexed citations

Kemmer, Christian, Adrien Herlédan, Rosangela Frita, et al.. (2019). A fragment-based approach towards the discovery of N-substituted tropinones as inhibitors of Mycobacterium tuberculosis transcriptional regulator EthR2. European Journal of Medicinal Chemistry. 167. 426–438. 14 indexed citations

10.

Trebosc, Vincent, Marcus Tötzl, Michel Pieren, et al.. (2019). Dissecting Colistin Resistance Mechanisms in Extensively Drug-Resistant Acinetobacter baumannii Clinical Isolates. mBio. 10(4). 94 indexed citations

11.

Trebosc, Vincent, Pablo Manfredi, Marcus Tötzl, et al.. (2016). A Novel Genome-Editing Platform for Drug-Resistant Acinetobacter baumannii Reveals an AdeR-Unrelated Tigecycline Resistance Mechanism. Antimicrobial Agents and Chemotherapy. 60(12). 7263–7271. 34 indexed citations

12.

Grau, Thomas, Petra Selchow, Marcel Tigges, et al.. (2011). Phenylethyl Butyrate Enhances the Potency of Second-Line Drugs against Clinical Isolates of Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy. 56(2). 1142–1145. 14 indexed citations

13.

Gitzinger, Marc, Christian Kemmer, David A. Fluri, et al.. (2011). The food additive vanillic acid controls transgene expression in mammalian cells and mice. Nucleic Acids Research. 40(5). e37–e37. 100 indexed citations

14.

Gitzinger, Marc, Christian Kemmer, Marie Daoud El‐Baba, Wilfried Weber, & Martin Fussenegger. (2009). Controlling transgene expression in subcutaneous implants using a skin lotion containing the apple metabolite phloretin. Proceedings of the National Academy of Sciences. 106(26). 10638–10643. 85 indexed citations

15.

Gitzinger, Marc, Juliana Parsons, Ralf Reski, & Martin Fussenegger. (2008). Functional cross‐kingdom conservation of mammalian and moss (Physcomitrella patens) transcription, translation and secretion machineries. Plant Biotechnology Journal. 7(1). 73–86. 34 indexed citations

16.

Weber, Wilfried, Ronald G. Schoenmakers, Bettina Keller, et al.. (2008). A synthetic mammalian gene circuit reveals antituberculosis compounds. Proceedings of the National Academy of Sciences. 105(29). 9994–9998. 129 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact